We experience the culture of globalisation every time we visit a Tandoori restaurant in Chicago, or a Pizza Hut in Hyderabad, or as we watch Bollywood films in Australia. Globalisation is a label used for a wide range of political, social and cultural phenomena, many of which are explored in this volume. The Politics and Culture of Globalisation: India and Australia brings together Indian and Australian experts in the fields of political science, international relations, philosophy, cultural theory and political economy. Its timeliness and unifying theme derive from comparisons between Indian and Australian perspectives, and analyses by Australian writers on developments in India. Indian-Australian relations are explored in several chapters. The neo-liberal form of globalisation is a key focus of critique in this volume. Several chapters examine the search for alternative forms of governance as the nation-state undergoes profound change due to global interconnectedness.

The book studies the pharmaceutical industry of India. It is one of the most successful stories of economic expansion and improvements in public health. Indian firms have made access to quality medicines possible and affordable in many developing countries. Indian pharmaceuticals are also exported on a large scale to the United States and other highly regulated markets. A wave of mergers, acquisitions and tie-ups point to growing integration between Indian firms and global pharma multinationals. Please note: Taylor & Francis does not sell or distribute the Hardback in India, Pakistan, Nepal, Bhutan, Bangladesh and Sri Lanka

Some two decades will shortly have passed since the WTO's Trade Related Aspects of Intellectual Property Rights agreement came into force in 1995. TRIPS is widely considered to have had a negative impact on access to medicines through its rules on pharmaceutical patents. This volume is the first cross-country analysis of how TRIPS has affected the capacity of 11 major low or medium income countries to produce generic drugs and assesses the wider political economy of drug production and consumption in the Global South.

Some two decades will shortly have passed since the WTO's Trade Related Aspects of Intellectual Property Rights agreement came into force in 1995. This volume is the first cross-country analysis of how TRIPS has affected the capacity of 11 major low or medium income countries to produce generic drugs.

This book examines the important role of consumer activism in health policy in different national contexts. In an age of shifting boundaries between state and civil society, consumer groups are potentially drivers of democratization in the health domain. The expert contributors explore how their activities bring new dynamics to relations between service providers, the medical profession, government agencies, and other policy actors. This book is unique in comprehensively analyzing the opportunities and dilemmas of this type of activism, including ambiguous partnerships between consumer groups and stakeholders such as the pharmaceutical industry. These themes are explored within an internationally comparative framework, with case studies from various countries. Students and researchers in the fields of health policy and sociology, public policy and social movements will find this relevant and path-breaking book enlightening. It will also prove invaluable for participants and activists in patient and health consumer organizations. Contributors include: K. Adams, W. Armstrong, R. Baggott, R. Bal, S. Barraclough, G. Braunegger-Kallinger, J. Church, D. Delnoij, R. Edwards, R. Forster, M. Fox, B. Fredericks, J. Geissler, P.C. John, K. Jones, M. Koivusalo, K. Krajic, A. Lambertson, M. Leahy, D. Legge, H. Lofgren, T. Milewa, C. Nunez Daw, O. O'Donovan, K.-L. Phua, A. Schipaanboord, J. Tritter, D. Truong, P. Vaillancourt Rosenau, A. Vitry